Boron-containing proteasome inhibitors for use after primary cancer therapy
MA39964AUndetermined Publication Date: 2015-11-26MILLENNIUM PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA39964
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2014-12-05
- Filing Date
- 2015-05-19
- Publication Date
- 2015-11-26
Abstract
The present disclosure relates to methods or dosing regimens comprising a proteasome inhibitor of formula (i), or a pharmaceutically acceptable salt thereof, for treating cancer, or preventing cancer recurrence or progression; wherein ring a, z
Need to check novelty before this filing date? Find Prior Art